Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis

Last updated: July 20, 2023
Sponsor: University Hospital, Brest
Overall Status: Active - Recruiting

Phase

N/A

Condition

Ear Infections (Pediatric)

Ear Infections

Vestibular Hypofunction

Treatment

Caloric test

EHTEV questionnaire

Angle of deviation at Fukuda

Clinical Study ID

NCT04678167
29BRC20.0040
  • Ages > 18
  • All Genders

Study Summary

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • adult patients,
  • patient with vestibular neuritis defined by appearance of continuous rotating vertigowith nausea
  • patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
  • patient with a postural deviation towards the affected ear;
  • vestibular hyporeflexia measured at the caloric tests greater than 25%
  • patient who has given free, enlighten and written consent

Exclusion

Exclusion Criteria:

  • patient with a history of vertigo of vestibular origin or with vertigo developing formore than 4 days
  • patient with associated hearing loss or tinnitus
  • patient with an motor ocular abnormality of central origin
  • patient refusal or inability to consent

Study Design

Total Participants: 51
Treatment Group(s): 7
Primary Treatment: Caloric test
Phase:
Study Start date:
March 10, 2021
Estimated Completion Date:
March 10, 2027

Connect with a study center

  • CHU de Brest

    Brest, 29200
    France

    Active - Recruiting

  • CH Pays de Morlaix

    Morlaix, 29672
    France

    Terminated

  • CH de Cornouaille Quimper

    Quimper, 29107
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.